T2 Biosystems, Inc. — Form D

T2 Biosystems, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-27. The offering totals $39.7M, of which $39.7M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Josh A Bilenker, M.D.DirectorLexington, MA
Michael A Cima, Ph.D.DirectorLexington, MA
John W CummingDirectorLexington, MA
David W ElsbreeDirectorLexington, MA
Adrian M JonesDirectorNew York, NY
Stanley M LapidusDirectorLexington, MA
Seymour M LiebmanDirectorLexington, MA
John McDonoughDirectorNew York, NY
Rahul M DhandaExecutive OfficerLexington, MA
Michael M Gibbs, Esq.Executive OfficerLexington, MA
David P HardingExecutive OfficerLexington, MA
Tom Lowery, Ph.D.Executive OfficerLexington, MA
Shawn LynchExecutive OfficerLexington, MA
John McDonoughExecutive OfficerNew York, NY
Michael A Pfaller, M.D.Executive OfficerLexington, MA
Steven M ScampiniExecutive OfficerLexington, MA
Joanne Spadoro, Ph.D.Executive OfficerLexington, MA
Robert LangerDirectorPittsburgh, PA
Michael CimaDirectorCambridge, MA
Michael GreeleyDirectorBoston, MA
Alan CraneDirectorWatertown, MA
Thomas LoweryExecutive OfficerCambridge, MA
Stacy FeldDirectorRedwood City, CA
HARRY WILCOXDirectorMEDFORD, MA
Stan LapidusDirectorLexington, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2013-03-28D$400.0M$400.0M
2011-08-10D$23.0M$23.0M
2010-05-28D$20.0M$14.8M

More